SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.88+0.2%Nov 25 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (16863)5/20/2004 5:27:20 PM
From: Bluegreen   of 17367
 
George, in my opinion this is an IMPORTANT metric for the the European regulatory officials. AND YES ONCE AGAIN THIS IS OLD NEWS!!!!!!!!!!!!! How could they turn Raptiva down with these subset results????????? AND not long ago I was seriously doubting European approval not to say it is a done deal BUT I think this CLEAR trial subset is an IMPORTANT metric!!!!! GO GET EM' SERONO!!!!!!! Down on the corner, OUT IN THE STREET!!!!!! WILLIE and the POOR BOYS are PLAYING, bring a nickel TAP YOUR FEET!!!!!!!!! Has the fun meter been pegged out yet??????............BLUEGREEN IS BACK!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!>>>>>>>>>>>http://www.serono.com/media/stories2004/20040430_en.jsp?major=4&minor=1
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext